Has Steven Dellose, MD received payments from drug or device companies?

Yes. Drug and device makers reported $51,762 in general payments to Steven Dellose, MD across 138 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Dellose, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Dellose, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Dellose, MD

Orthopaedic Surgery · Wilmington, DENPI 1679512685

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (42.7%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. Ortho Development Corporation accounts for 78.6% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $18,692, 2.9 times the $6,517 reported in 2019.

$51,762in general payments, 2019–2025

Across 138 payments — averaging $375.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Ortho Development Corporation$41K
Medical Device Business Services, Inc.$8K
Johnson & Johnson$999
Stryker$544
Amgen$396
Zimmer Biomet$172
plus $835 from 15 others

What the payments were for

Royalty or licence$13,11325%
Consulting fees$22,10043%
Speaking & faculty fees$8,50016%
Travel & lodging$4,0738%
Food & beverage$3,9768%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Ortho Development Corporation	44	$40,696
Medical Device Business Services, Inc.	4	$8,122
Johnson & Johnson	20	$999
Stryker(2 entities)	14	$544
Amgen	30	$396
Zimmer Biomet	3	$172
Davol Inc.	2	$157
Smith+Nephew	2	$147
Medacta USA, Inc.	1	$108
Ferring Pharmaceuticals Inc.	5	$85
Eclipse Technology Solutions Inc.	2	$69
Pacira Cryotech Incorporated	1	$63
Nextstep Arthropedix, LLC	1	$60
Fidia Pharma USA Inc.	2	$33
Acell, Inc.	1	$21
Vericel Corporation	1	$19
Sanofi-aventis U.S. LLC	1	$16
Convatec Inc.	1	$16
Pacira Pharmaceuticals Incorporated	1	$15
Pacira Therapeutics, Inc.	1	$14
Arthrosurface Incorporated	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$51,762 in reported general payments places this provider in the 85th percentile of 70 orthopaedic surgery providers in Delaware.

See all orthopaedic surgery providers in Delaware →

Medicare billing

Part B allowed, 2024

$1,421,961

Medicare patients

1,570

Services billed

24,872

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	307	$7,619
Oxycodone Hcl	465	$2,952
Ondansetron Hcl	182	$1,303
Gabapentin	264	$980
Omeprazole	74	$860
Meloxicam	184	$753
Diazepam	231	$685
Amoxicillin	347	$592
Azithromycin	28	$516
Tramadol Hcl	134	$491
Mupirocin	63	$280
Ibuprofen	28	$270
Cephalexin	11	$259
Hydromorphone Hcl	36	$214
Clindamycin Hcl	13	$70

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Wilmington

Suken ShahWilmington$2.1M
Patrick WardWilmington$68K
James RubanoWilmington$39K
Nicholas QuercettiWilmington$32K
Michael PrincipeWilmington$29K
David TainterWilmington$26K
Akul PatelWilmington$21K
Alfonso ArevaloWilmington$18K
Michael ShraderWilmington$14K
Brian GalinatWilmington$13K

See the full list for Delaware →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →